Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT
· Real-Time Price · USD
7.68
-0.99 (-11.42%)
At close: Aug 15, 2025, 3:59 PM
7.83
1.95%
After-hours: Aug 15, 2025, 07:47 PM EDT
Sagimet Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | 2M | 2M | 2M | 2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | 35K | 69K | 103K | 103K | 68K | 34K | 32K | 32K | 65K | 65K | 63K |
Gross Profit | n/a | n/a | n/a | n/a | 1.97M | 1.93M | 1.9M | 1.9M | -68K | -34K | -32K | -32K | -65K | -65K | -63K |
Operating Income | -66.89M | -65.55M | -54.45M | -45.73M | -36.27M | -32.74M | -30.74M | -28.66M | -28.9M | -29.08M | -31.05M | -23.67M | -20.78M | -13.55M | -8.81M |
Interest Income | 5.97M | 8.44M | 8.89M | 8.21M | 7.02M | 4.82M | 2.86M | 1.74M | 862K | 727K | 553K | 360K | 148K | 12K | 32K |
Pretax Income | -59.38M | -57.11M | -45.57M | -37.52M | -29.25M | -27.92M | -27.88M | -26.92M | -28.03M | -28.35M | -30.5M | -23.3M | -21.39M | -14.28M | -9.53M |
Net Income | -59.38M | -57.11M | -45.57M | -37.52M | -29.25M | -27.92M | -27.88M | -26.92M | -28.03M | -28.35M | -30.5M | -23.3M | -21.39M | -14.28M | -9.53M |
Selling & General & Admin | 17.43M | 17.03M | 16.01M | 15.84M | 16.09M | 14.19M | 12.96M | 10.69M | 7.05M | 5.53M | 6.14M | 4.59M | 5.2M | 4.33M | 2.43M |
Research & Development | 49.46M | 48.52M | 38.44M | 29.88M | 22.19M | 20.55M | 19.78M | 19.97M | 21.85M | 23.54M | 24.92M | 19.07M | 15.59M | 9.22M | 6.38M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -2K | -2K | -2K | -2K | 2K | 2K | 2K | 2K | -2K |
Operating Expenses | 66.89M | 65.55M | 54.45M | 45.73M | 38.27M | 34.74M | 32.74M | 30.66M | 28.9M | 29.08M | 31.05M | 23.67M | 20.78M | 13.55M | 8.81M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 66.89M | 65.55M | 54.45M | 45.73M | 38.27M | 34.74M | 32.74M | 30.66M | 28.9M | 29.08M | 31.05M | 23.67M | 20.78M | 13.55M | 8.81M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -38K | -38K | -77K | -77K | -39K |
Shares Outstanding (Basic) | 32.2M | 32.2M | 32.2M | 32.14M | 31.91M | 29.04M | 18.19M | 18.19M | 22.17M | 22.17M | 22.17M | 22.17M | 22.17M | 22.17M | 22.17M |
Shares Outstanding (Diluted) | 32.2M | 32.2M | 32.2M | 32.14M | 31.91M | 29.04M | 18.19M | 18.19M | 22.17M | 22.17M | 22.17M | 22.17M | 22.17M | 22.17M | 22.17M |
EPS (Basic) | -1.83 | -1.76 | -1.43 | -1.38 | -1.28 | -1.34 | -1.41 | -1.28 | -1.27 | -1.28 | -1.37 | -1.05 | -0.96 | -0.64 | -0.43 |
EPS (Diluted) | -1.83 | -1.76 | -1.43 | -1.38 | -1.28 | -1.34 | -1.41 | -1.28 | -1.27 | -1.28 | -1.37 | -1.05 | -0.96 | -0.64 | -0.43 |
EBITDA | -64.89M | -63.56M | -43.69M | -34.27M | -24.82M | -20.98M | -27.54M | -20.76M | -13.3M | -6.55M | -8.7M | -8.7M | -13.51M | -13.51M | -8.81M |
EBIT | -63.35M | -63.56M | -52.46M | -45.73M | -36.27M | -32.74M | -30.74M | -28.66M | -28.9M | -29.08M | -31.05M | -23.67M | -20.78M | -13.55M | -8.81M |
Depreciation & Amortization | n/a | n/a | 8.77M | 18.23M | 18.23M | 18.27M | 9.53M | 7.46M | 15.14M | 22.35M | 22.34M | 14.96M | 7.3M | 65K | 63K |